Cumberland Hospital Psychiatry & Neurology - Child & Adolescent Psychiatry Medicare: Not Enrolled in Medicare Practice Location: 9407 Cumberland Rd, New Kent, VA 23124 Phone: 804-966-2242 |
Spectrum Health Solutions Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 5615 Buckhunt Ln, New Kent, VA 23124 Phone: 757-784-2987 |
Evolve Behavioral Health And Wellness Llc Community/Behavioral Health Agency Medicare: Not Enrolled in Medicare Practice Location: 6033 Bushnell Dr, New Kent, VA 23124 Phone: 518-928-3261 |
News Archive
Family doctors and psychiatrists should carefully monitor the heart health of patients with anxiety disorders, Dr. Simon Bacon told the Canadian Cardiovascular Congress 2008, co-hosted by the Heart and Stroke Foundation and the Canadian Cardiovascular Society. "People with anxiety disorders are four times more likely to develop high blood pressure (hypertension) over one year than those of us who are anxiety free," says Dr. Bacon, a Heart and Stroke Foundation researcher at the Montreal Heart Institute. "Hypertension is a leading risk factor for stroke and heart disease."
Medicity—the leading provider of health information exchange (HIE) solutions that empower physicians, hospitals and communities to improve care coordination, collaboration and achieve meaningful use of health information technology—today announced the U.S. Patent and Trademark Office has awarded the company Patent No. 7,653,634 for its agent-grid technology for health information exchange. This patented technology, which is at the core of Medicity's Novo Grid, has become the industry standard for seamless electronic health record (EHR) integration and community-wide health information exchange.
The Associated Press: "Millions of seniors signed up for popular Medicare Advantage insurance plans don't get the best quality, an independent study found. How the private plans score on a quality rating system set up by the government is about to have a direct impact on insurers' finances — not to mention seniors' benefits and premiums.
NovaDigm Therapeutics, a company developing innovative vaccines for fungal and bacterial infections, today announced the presentation of positive data from a preclinical study evaluating the efficacy its NDV-3 vaccine in a model of vulvovaginal candidiasis (VVC), which is primarily caused by Candida albicans.
A research team led by UT Southwestern Medical Center scientists has identified an atypical metabolic pathway unique to some tumors, possibly providing a future target for drugs that could reduce or halt the spread of cancer.
› Verified 9 days ago